Bod Australia: Clinical Trials

4 trials sponsored by Bod Australia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown. 2 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Unknown 1
Phase 41Unknown 1

Follow Bod Australia: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The CANabidiol Use for RElief of Short Term Insomnia
50 mg Cannabidiol (CBD), Placebo, 100 mg Cannabidiol (CBD) - Sleep Disturbance, Insomnia
Phase 2CompletedBod Australia2082022-05-012023-08-16
Feasibility of Cannabidiol for the Treatment of Long COVID
MediCabilis Cannabis sativa 50 - Long COVID
Phase 2CompletedBod Australia122022-04-142023-01-19
EMERALD TRIAL Open Label Extension Study
MediCabilis CBD oil - Amyotrophic Lateral Sclerosis, Cannabis
Phase 4UnknownGold Coast Hospital and Health Service72021-05-172023-04-03
Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease
MediCabilis CBD Oil, Placebo Oil - Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Phase 3UnknownGold Coast Hospital and Health Service172019-01-092023-04-03

Conditions studied

Amyotrophic Lateral Sclerosis (2)  ·  Motor Neuron Disease (2)  ·  Anxiety Disorders (1)  ·  Fatigue (1)  ·  Marijuana Abuse (1)  ·  Parasomnias (1)  ·  Post-Acute COVID-19 Syndrome (1)  ·  Psychological Well-Being (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Sleep Wake Disorders (1)

Interventions

Cannabidiol (1)  ·  Capsules (1)

Countries

Australia (3)  ·  United Kingdom (1)

Top investigators

Elizabeth Iveson (1)  ·  Ron Grunstein (1)

Results publications

PMID 31719072